Skip to main content
Premium Trial:

Request an Annual Quote

VistaGen, Capsant To Co-market Stem Cell-based Drug Screening Platforms

NEW YORK (GenomeWeb News) — VistaGen will offer its stem cell-based screening platform with Capsant's cell culture system under a commercialization agreement focused on technologies for new programs that would use stem cell technologies to change the clinical trial process, VistaGen said today.

Vistagen's "Clinical Trials in a Test Tube" platform is aimed at generating predictive information about drug trial failures, particularly those involving liver and heart toxicity. Capsant's OrganDot 3D technology is a high-throughput, in vitro drug testing system using stem cell-based 3D tissue cultures.

VistaGen CEO Ralph Snodgrass said the agreement enables the two companies to offer "reproducible, mature, and functional human cells that grow as 3D 'micro-organs' in a commercially scalable platform with integrated analytical capabilities."

"This new agreement advances our common goal of providing new-generation drug development tools that are a vital necessity to improve drug R&D productivity in the pharmaceutical industry," he continued.

Capsant is headquartered in Southampton, UK, and VistaGen is based in South San Francisco.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.